Ge Healthcare Technologies INC Form 4 insider transactions

NASDAQ
Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., sold shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Peter J. Arduini, President and CEO of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Director Culp H Lawrence Jr. of GE HealthCare Technologies Inc. reports disposition of shares to cover tax obligations.
NASDAQ
Chief People Officer Adam Holton reports the acquisition of restricted stock and stock options in GE HealthCare Technologies Inc.
NASDAQ
Roland Rott, CEO, Imaging, of GE HealthCare Technologies Inc., reports the acquisition of restricted stock units and employee stock options.
NASDAQ
Philip Rackliffe, CEO of Ultrasound & IGT at GE HealthCare Technologies Inc., reports the acquisition of restricted stock units and an employee stock option.
NASDAQ
Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., sold 19,008 shares of common stock at a price of $83.22 per share on August 14, 2024.
NASDAQ
Thomas Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., sold 2,750 shares of common stock at an average price of $80.78 on August 7, 2024.
NASDAQ
CEO of Imaging at GE HealthCare Technologies, Roland Rott, reports disposition of shares to cover tax obligations related to vesting of restricted stock units.
NASDAQ
Kevin Michael O'Neill, CEO, PDx of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Chief Financial Officer of GE HealthCare Technologies Inc., James Saccaro, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., sold 3,300 shares of common stock at an average price of $78.70 on May 28, 2024.
NASDAQ
Director Phoebe L. Yang Watkin acquired 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.
NASDAQ
Director William J. Stromberg acquired shares of GE HealthCare Technologies Inc. through restricted stock units and deferred stock units.
NASDAQ
Director Tomislav Mihaljevic reports acquisition of 2,440 shares of GE HealthCare Technologies Inc. common stock through restricted stock units.
NASDAQ
Director Anne T. Madden reports the acquisition of restricted stock units and deferred stock units in GE HealthCare Technologies Inc.
NASDAQ
Director Catherine A. Lesjak acquired 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.
NASDAQ
Director Risa J. Lavizzo-Mourey acquired 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.
NASDAQ
Director Howell Lloyd Jr. reports the acquisition of 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.
NASDAQ
Director Rodney F. Hochman acquired shares of GE HealthCare Technologies Inc. through restricted stock units and deferred stock units.
NASDAQ
H Lawrence Culp Jr., a director at GE HealthCare Technologies Inc., reported the acquisition of 2,440 restricted stock units.
NASDAQ
GE HealthCare's CEO, Jan Makela, exercised employee stock options and sold shares of common stock on May 13 and May 15, 2024.
NASDAQ
Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., purchased 1,315 shares of common stock at $76.52 per share on May 1, 2024.
NASDAQ
Roland Rott, CEO of Ultrasound at GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
General Electric Co. exchanged 14,000,000 shares of GE HealthCare Technologies common stock to extinguish $1,221,780,000 of debt, resulting in GE no longer being a 10% beneficial owner.
NASDAQ
Thomas Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reports the withholding of shares for tax obligations and the award of restricted stock units and employee stock options.
NASDAQ
Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., reports acquisition of common stock and stock options.
NASDAQ
Chief Financial Officer James Saccaro reported the acquisition of restricted stock units and employee stock options in GE HealthCare Technologies Inc.
NASDAQ
CEO of Ultrasound at GE HealthCare Technologies, Roland Rott, reports the withholding of shares for tax obligations and the award of restricted stock units and employee stock options.